Christopher Bunka - 17 Mar 2026 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
Director
Signature
/Chris Bunka/
Issuer symbol
LEXX
Transactions as of
17 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 11:37:13 UTC
Previous filing
30 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BUNKA CHRISTOPHER Director SUITE 100, 740 MCCURDY ROAD, KELOWNA, BRITISH COLUMBIA, CANADA /Chris Bunka/ 18 Mar 2026 0001103780

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LEXX common shares Gift -100,000 -27% $0.000000* 273,543 17 Mar 2026 Direct F1
holding LEXX common shares 373,543 17 Mar 2026 Direct
holding LEXX common shares 281,912 17 Mar 2026 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LEXX Stock Options 26,000 17 Mar 2026 Common Shares 26,000 $3.00 Direct
holding LEXX Stock Options 49,334 17 Mar 2026 Common Shares 23,334 $3.00 Direct
holding LEXX Stock Options 64,334 17 Mar 2026 Common Shares 15,000 $3.00 Direct
holding LEXX Stock Options 94,334 17 Mar 2026 Common Shares 30,000 $2.91 Direct
holding LEXX Stock Options 124,334 17 Mar 2026 Common Shares 30,000 $1.15 Direct
holding LEXX Stock Options 173,834 17 Mar 2026 Common Shares 49,500 $2.36 Direct
holding LEXX Stock Options 184,834 17 Mar 2026 Common Shares 11,000 $1.04 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 100,000 shares were gifted back to Lexaria Bioscience Corp. and returned to treasury.